DoD Gulf War Illness Innovative Treatment Evaluation Award

Funding Opportunity Number: W81XWH-15-GWIRP-ITEA Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementGrantCategory of Funding Activity: Science and Technology and other Research and DevelopmentCFDA Number: 12.420Eligible Applicants Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"Agency Name: DOD-AMRAAClosing Date: Oct 29, 2015Award Ceiling: $0Expected Number of Awards: 3Creation Date: May 14, 2015Funding Opportunity Description: The FY15 GWIRP is offering two award mechanisms to evaluate potential interventions for GWI: the Innovative Treatment Evaluation Award and the Clinical Trial Award. The Innovative Treatment Evaluation Award, described in this Program Announcement, supports the initial evaluation of a treatment or intervention in early phase or pilot clinical trials (Phase 0, I, or I/II), and does not require preliminary data. These trials will hereafter collectively be referred to as “pilot clinical trials.” In contrast, the Clinical Trial Award is intended to support larger, more definitive (Phase II-III, U.S. Food and Drug Administration [FDA] device class I-III) clinical trials. (For information about the Clinical Trial Award, see http://cdmrp.army.mil/funding/gwirp.shtml.) The Innovative Treatment Evaluation Award mechanism was first offered in FY08. Since then, 42 Innovative Treatment Evalua...
Source: Grants.gov - Category: Research Tags: Science and Technology and other Research and Development Source Type: funding